On the other hand, COVID-19 immunization strategies that use the RBD of the S protein have been demonstrated to stimulate high titers of NAbs and long-lasting humoral protective immunity, providing a high chance of success with minimal risk of ADE (179, 180). The gene discussed is PROS1; the disease is COVID-19.